nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Thalidomide—leprosy	0.222	0.263	CbGbCtD
Glipizide—CYP2C9—Rifampicin—leprosy	0.215	0.255	CbGbCtD
Glipizide—CYP2C9—Dapsone—leprosy	0.177	0.211	CbGbCtD
Glipizide—CYP3A4—Rifampicin—leprosy	0.125	0.148	CbGbCtD
Glipizide—CYP3A4—Dapsone—leprosy	0.103	0.122	CbGbCtD
Glipizide—Foetor hepaticus—Thalidomide—leprosy	0.00519	0.0369	CcSEcCtD
Glipizide—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00507	0.036	CcSEcCtD
Glipizide—Liver disorder—Thalidomide—leprosy	0.00432	0.0307	CcSEcCtD
Glipizide—PPARG—hindlimb—leprosy	0.00432	0.259	CbGeAlD
Glipizide—PPARG—appendage—leprosy	0.00371	0.222	CbGeAlD
Glipizide—Jaundice cholestatic—Thalidomide—leprosy	0.00335	0.0238	CcSEcCtD
Glipizide—Photosensitivity reaction—Dapsone—leprosy	0.0033	0.0234	CcSEcCtD
Glipizide—Gait disturbance—Thalidomide—leprosy	0.00302	0.0214	CcSEcCtD
Glipizide—Hepatocellular injury—Thalidomide—leprosy	0.00295	0.0209	CcSEcCtD
Glipizide—Pharyngitis—Dapsone—leprosy	0.00287	0.0204	CcSEcCtD
Glipizide—Aplastic anaemia—Thalidomide—leprosy	0.00277	0.0196	CcSEcCtD
Glipizide—Cramps of lower extremities—Thalidomide—leprosy	0.00271	0.0192	CcSEcCtD
Glipizide—Hypertonia—Thalidomide—leprosy	0.00258	0.0183	CcSEcCtD
Glipizide—Erythema—Dapsone—leprosy	0.00252	0.0179	CcSEcCtD
Glipizide—Eczema—Thalidomide—leprosy	0.00238	0.0169	CcSEcCtD
Glipizide—Vision blurred—Dapsone—leprosy	0.00237	0.0168	CcSEcCtD
Glipizide—Libido decreased—Thalidomide—leprosy	0.00231	0.0164	CcSEcCtD
Glipizide—Vertigo—Dapsone—leprosy	0.00226	0.016	CcSEcCtD
Glipizide—Visual disturbance—Thalidomide—leprosy	0.00226	0.016	CcSEcCtD
Glipizide—Hypoglycaemia—Thalidomide—leprosy	0.00219	0.0156	CcSEcCtD
Glipizide—Hyponatraemia—Thalidomide—leprosy	0.00215	0.0152	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00214	0.0152	CcSEcCtD
Glipizide—Diplopia—Thalidomide—leprosy	0.00214	0.0152	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Thalidomide—leprosy	0.00212	0.0151	CcSEcCtD
Glipizide—Migraine—Thalidomide—leprosy	0.0021	0.0149	CcSEcCtD
Glipizide—PPARG—blood vessel—leprosy	0.00206	0.124	CbGeAlD
Glipizide—Insomnia—Dapsone—leprosy	0.00186	0.0132	CcSEcCtD
Glipizide—Pancytopenia—Thalidomide—leprosy	0.00176	0.0125	CcSEcCtD
Glipizide—Photosensitivity reaction—Thalidomide—leprosy	0.00169	0.012	CcSEcCtD
Glipizide—Gastrointestinal pain—Dapsone—leprosy	0.00168	0.0119	CcSEcCtD
Glipizide—Drowsiness—Thalidomide—leprosy	0.00165	0.0117	CcSEcCtD
Glipizide—Abdominal pain—Dapsone—leprosy	0.00162	0.0115	CcSEcCtD
Glipizide—Conjunctivitis—Thalidomide—leprosy	0.0016	0.0114	CcSEcCtD
Glipizide—Sweating—Thalidomide—leprosy	0.00158	0.0112	CcSEcCtD
Glipizide—Agranulocytosis—Thalidomide—leprosy	0.00154	0.0109	CcSEcCtD
Glipizide—Rhinitis—Thalidomide—leprosy	0.00148	0.0105	CcSEcCtD
Glipizide—Hepatitis—Thalidomide—leprosy	0.00148	0.0105	CcSEcCtD
Glipizide—Hypoaesthesia—Thalidomide—leprosy	0.00147	0.0104	CcSEcCtD
Glipizide—Pharyngitis—Thalidomide—leprosy	0.00147	0.0104	CcSEcCtD
Glipizide—Visual impairment—Thalidomide—leprosy	0.00143	0.0101	CcSEcCtD
Glipizide—Eye disorder—Thalidomide—leprosy	0.00138	0.00981	CcSEcCtD
Glipizide—Chills—Thalidomide—leprosy	0.00133	0.00942	CcSEcCtD
Glipizide—Arrhythmia—Thalidomide—leprosy	0.00132	0.00938	CcSEcCtD
Glipizide—Vomiting—Dapsone—leprosy	0.00131	0.00927	CcSEcCtD
Glipizide—Headache—Dapsone—leprosy	0.00129	0.00913	CcSEcCtD
Glipizide—Flatulence—Thalidomide—leprosy	0.00127	0.00901	CcSEcCtD
Glipizide—Tension—Thalidomide—leprosy	0.00126	0.00897	CcSEcCtD
Glipizide—Nervousness—Thalidomide—leprosy	0.00125	0.00888	CcSEcCtD
Glipizide—Muscle spasms—Thalidomide—leprosy	0.00124	0.00879	CcSEcCtD
Glipizide—Nausea—Dapsone—leprosy	0.00122	0.00866	CcSEcCtD
Glipizide—Vision blurred—Thalidomide—leprosy	0.00121	0.00862	CcSEcCtD
Glipizide—Tremor—Thalidomide—leprosy	0.00121	0.00856	CcSEcCtD
Glipizide—Ill-defined disorder—Thalidomide—leprosy	0.00119	0.00848	CcSEcCtD
Glipizide—Malaise—Thalidomide—leprosy	0.00116	0.00824	CcSEcCtD
Glipizide—Vertigo—Thalidomide—leprosy	0.00116	0.00821	CcSEcCtD
Glipizide—Syncope—Thalidomide—leprosy	0.00115	0.0082	CcSEcCtD
Glipizide—Leukopenia—Thalidomide—leprosy	0.00115	0.00818	CcSEcCtD
Glipizide—Loss of consciousness—Thalidomide—leprosy	0.00113	0.00803	CcSEcCtD
Glipizide—Hypertension—Thalidomide—leprosy	0.00111	0.00789	CcSEcCtD
Glipizide—Arthralgia—Thalidomide—leprosy	0.0011	0.00778	CcSEcCtD
Glipizide—Myalgia—Thalidomide—leprosy	0.0011	0.00778	CcSEcCtD
Glipizide—Anxiety—Thalidomide—leprosy	0.00109	0.00776	CcSEcCtD
Glipizide—Discomfort—Thalidomide—leprosy	0.00108	0.00769	CcSEcCtD
Glipizide—Confusional state—Thalidomide—leprosy	0.00106	0.00752	CcSEcCtD
Glipizide—Oedema—Thalidomide—leprosy	0.00105	0.00746	CcSEcCtD
Glipizide—Shock—Thalidomide—leprosy	0.00103	0.00734	CcSEcCtD
Glipizide—KCNJ11—tendon—leprosy	0.00103	0.062	CbGeAlD
Glipizide—Thrombocytopenia—Thalidomide—leprosy	0.00103	0.0073	CcSEcCtD
Glipizide—Hyperhidrosis—Thalidomide—leprosy	0.00102	0.00721	CcSEcCtD
Glipizide—Anorexia—Thalidomide—leprosy	0.001	0.00711	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Thalidomide—leprosy	0.000958	0.0068	CcSEcCtD
Glipizide—PPARG—skin of body—leprosy	0.000955	0.0573	CbGeAlD
Glipizide—Insomnia—Thalidomide—leprosy	0.000951	0.00675	CcSEcCtD
Glipizide—Paraesthesia—Thalidomide—leprosy	0.000944	0.0067	CcSEcCtD
Glipizide—Dyspnoea—Thalidomide—leprosy	0.000937	0.00665	CcSEcCtD
Glipizide—Somnolence—Thalidomide—leprosy	0.000934	0.00663	CcSEcCtD
Glipizide—Dyspepsia—Thalidomide—leprosy	0.000925	0.00657	CcSEcCtD
Glipizide—Decreased appetite—Thalidomide—leprosy	0.000914	0.00649	CcSEcCtD
Glipizide—Gastrointestinal disorder—Thalidomide—leprosy	0.000907	0.00644	CcSEcCtD
Glipizide—Constipation—Thalidomide—leprosy	0.000899	0.00638	CcSEcCtD
Glipizide—Pain—Thalidomide—leprosy	0.000899	0.00638	CcSEcCtD
Glipizide—Feeling abnormal—Thalidomide—leprosy	0.000866	0.00615	CcSEcCtD
Glipizide—Gastrointestinal pain—Thalidomide—leprosy	0.00086	0.0061	CcSEcCtD
Glipizide—KCNJ11—nervous system—leprosy	0.00084	0.0504	CbGeAlD
Glipizide—Urticaria—Thalidomide—leprosy	0.000835	0.00593	CcSEcCtD
Glipizide—Abdominal pain—Thalidomide—leprosy	0.000831	0.0059	CcSEcCtD
Glipizide—ABCC8—testis—leprosy	0.000789	0.0473	CbGeAlD
Glipizide—Hypersensitivity—Thalidomide—leprosy	0.000774	0.0055	CcSEcCtD
Glipizide—ABCC8—nervous system—leprosy	0.000774	0.0464	CbGeAlD
Glipizide—Asthenia—Thalidomide—leprosy	0.000754	0.00535	CcSEcCtD
Glipizide—Pruritus—Thalidomide—leprosy	0.000744	0.00528	CcSEcCtD
Glipizide—PPARG—tendon—leprosy	0.000727	0.0436	CbGeAlD
Glipizide—Diarrhoea—Thalidomide—leprosy	0.000719	0.0051	CcSEcCtD
Glipizide—Dizziness—Thalidomide—leprosy	0.000695	0.00493	CcSEcCtD
Glipizide—Vomiting—Thalidomide—leprosy	0.000668	0.00474	CcSEcCtD
Glipizide—Rash—Thalidomide—leprosy	0.000663	0.0047	CcSEcCtD
Glipizide—Dermatitis—Thalidomide—leprosy	0.000662	0.0047	CcSEcCtD
Glipizide—Headache—Thalidomide—leprosy	0.000658	0.00467	CcSEcCtD
Glipizide—Nausea—Thalidomide—leprosy	0.000624	0.00443	CcSEcCtD
Glipizide—PPARG—testis—leprosy	0.000602	0.0361	CbGeAlD
Glipizide—PPARG—nervous system—leprosy	0.000591	0.0355	CbGeAlD
Glipizide—CYP3A4—nervous system—leprosy	0.000264	0.0158	CbGeAlD
